Market Overview

AbbVie Posts Strong Quarter, Raises Guidance

Share:
Related
Barron's Roundtable: A Big Basket Of Bargains For 2018
The Top 10 Value Stocks In The S&P 500
Stocks To Watch: Earnings Season Hits Higher Gear (Seeking Alpha)

AbbVie Inc (NYSE: ABBV) reported mixed results for the third quarter. While EPS topped by a penny, sales revenue fell shy of estimates. The company boosted its adjusted EPS forecast, but this apparently wasn't enough to satisfy investors.

  • Adjusted EPS increases 7 percent to $1.21, beats by a penny.
  • Delivers net revenues of $6.43 billion, misses by $0.13 billion.
  • Adjusted net revenues advanced 8 percent on an operational basis.
  • Boosts adjusted EPS forecast to $4.80-$4.82 versus Street expectations of $4.82.
  • Announces 12 percent dividend increase for 2017 with dividend payable in February.

Chairman and CEO Richard Gonzalez commented, "We delivered another strong quarter, with EPS growth ahead of our expectations. Year-to-date, we've driven strong commercial, operational and R&D execution, and we have advanced our pipeline and other strategic priorities."

Here is the complete press release: https://news.abbvie.com/news/abbvie-reports-third-quarter-2016-financial-results.htm

At last check, the stock fell 4 percent to $59.00 in the pre-market session.

Posted-In: Earnings News Guidance Movers

 

Related Articles (ABBV)

View Comments and Join the Discussion!